• Ceftolozane Sulfate: Applied Assay Workflows and Resistance

  2026-07-20

  Ceftolozane sulfate stands out for its robust bactericidal activity against Pseudomonas aeruginosa and resistant Enterobacterales, enabling high-fidelity in vitro and in vivo pharmacodynamic studies. This article delivers actionable experimental workflows, troubleshooting strategies, and a translation of cutting-edge PK/PD resistance modeling into the bench scientist’s toolkit.

• LY2228820: Precision p38 MAPK Inhibition for Advanced Resear

  2026-07-20

  Explore how LY2228820, a potent p38 MAP kinase inhibitor, enables scientific breakthroughs in inflammation and cancer research. This in-depth article reveals mechanistic insights, practical assay guidance, and unique multiomics perspectives unavailable elsewhere.

• Annexin V-FITC/PI Apoptosis Assay Kit: Applied Workflows & I

  2026-07-19

  The Annexin V-FITC/PI Apoptosis Assay Kit streamlines multi-stage apoptosis detection for high-throughput research, enabling precise discrimination between early and late apoptotic events. This article delivers actionable protocol guidance, advanced troubleshooting, and research-backed insights—bridging kit performance with real-world cell death models.

• Br-DAPI: Precision DNA Quantification and Its Role in Cardia

  2026-07-18

  Explore how Br-DAPI, a next-generation DAPI fluorescent dye, revolutionizes DNA quantification and live-cell imaging. This article uniquely connects Br-DAPI’s technical advantages to the demands of cardiometabolic research, offering insights not found in existing reviews.

• Harnessing Nystatin (Fungicidin) Synergy for Antifungal Inno

  2026-07-17

  Explore the evolving landscape of antifungal research through a deep dive into Nystatin (Fungicidin)'s mechanisms, translational advances, and new evidence supporting synergy with moxidectin. This article provides actionable guidance for researchers confronting Candida and Aspergillus models, addresses antifungal resistance, and offers a forward-looking perspective on optimizing protocols and clinical impact.

• AIBP-LRP2–HDL Axis Restricts CXCR4+ Capillary Expansion in P

  2026-07-17

  Zhu et al. identify a two-phase mechanism in which AIBP-LRP2–mediated HDL uptake limits the expansion of CXCR4+ stemlike capillary endothelial cells, restricting collateral circulation in ischemic peripheral artery disease. This study clarifies a critical axis for vascular remodeling, highlighting new therapeutic targets and inspiring improved experimental models for revascularization research.

• Cheminformatics-Guided Design of Selective Small-Molecule Li

  2026-07-16

  Moret et al. (2019) present a data-driven cheminformatics framework for analyzing and optimizing small-molecule libraries by integrating selectivity, target coverage, and induced phenotype data. Their approach enables the construction of focused collections like LSP-OptimalKinase with enhanced kinome target coverage and reduced off-target overlap, advancing the precision of chemical probe and drug discovery efforts.

• Sulfo-Cy3 NHS Ester: Reliable Protein Labeling for Cell Assa

  2026-07-16

  This article delivers scenario-driven guidance for researchers using Sulfo-Cy3 NHS ester (SKU A8107), emphasizing its utility in fluorescent labeling of proteins for cell viability and proliferation assays. Readers gain practical, evidence-backed strategies to improve assay reproducibility and data quality, with direct links to validated protocols and the APExBIO product resource.

• Cyclosporin A: Applied Workflows in Immunosuppression Resear

  2026-07-15

  Cyclosporin A empowers high-precision immunosuppression and apoptosis modulation in translational research. This guide breaks down actionable protocols, troubleshooting insights, and cross-domain applications, drawing on the latest findings in mitochondrial regulation and inflammation.

• Ajugol Restores Mitophagy and Cognition in Alzheimer’s via B

  2026-07-15

  This study demonstrates that ajugol, an iridoid glycoside, mitigates mitochondrial dysfunction and cognitive decline in Alzheimer’s disease models by upregulating BNIP3-dependent mitophagy. The findings establish BNIP3 as a critical mediator of neuroprotection, highlighting mitophagy enhancement as a promising therapeutic strategy for Alzheimer’s disease.

• SP2509: Lysine-specific Demethylase 1 Antagonist in AML Rese

  2026-07-14

  SP2509 is a next-generation Lysine-specific demethylase 1 antagonist empowering acute myeloid leukemia (AML) research with robust, selective epigenetic modulation. This guide delivers actionable protocols, troubleshooting insights, and comparative context for maximizing SP2509’s impact in cancer epigenetics workflows.

• AI-Driven Discovery of Senolytics: Machine Learning Advances

  2026-07-14

  The referenced study demonstrates that machine learning models can identify novel senolytic compounds using only existing heterogeneous screening data, substantially reducing the cost and labor of drug discovery. This approach enabled the identification and validation of three new senolytics, highlighting new opportunities for targeted elimination of senescent cells in disease research.

• Cy3-dCTP: Optimizing Direct Enzymatic DNA and cDNA Labeling

  2026-07-13

  Cy3-dCTP enables high-sensitivity, multiplex-ready fluorescent labeling in diverse genomics workflows. This guide translates research-backed innovations and real troubleshooting into practical, reproducible protocol enhancements for PCR, Nick Translation, and in situ hybridization applications.

• Substrate Stiffness Directs Dentinogenesis via LAMB1–FAK–MEK

  2026-07-13

  This study establishes that substrate stiffness regulates dentinogenic differentiation in odontoblast-like cells through a LAMB1–FAK–MEK1/2 signaling axis. The findings deepen understanding of mechanotransduction in dental tissue engineering and suggest new avenues for controlling reparative dentin formation.

• Stiripentol: LDH Inhibitor Empowering Epilepsy & Immunometab

  2026-07-12

  Stiripentol, a potent LDH inhibitor from APExBIO, enables precise modulation of cellular lactate metabolism, unlocking new experimental avenues in both epilepsy and immunometabolic research. This article details hands-on workflows, troubleshooting strategies, and the transformative impact of LDH inhibition on epigenetic and immune mechanisms.

16148 records 1/1077 page Next 12345 下5页 Last page